利福拉齐杂质的分析研究

张静霞,, 徐明琴,,陈林,,王宇驰,,张春然,,李喆宇,,石克金,,唐克慧,*

中国药学杂志 ›› 2015, Vol. 50 ›› Issue (7) : 639-645.

PDF(2162 KB)
PDF(2162 KB)
中国药学杂志 ›› 2015, Vol. 50 ›› Issue (7) : 639-645. DOI: 10.11669/cpj.2015.07.016
论著

利福拉齐杂质的分析研究

  • 张静霞1,2, 徐明琴1,2,陈林1,2,王宇驰1,2,张春然1,2,李喆宇1,2,石克金1,2,唐克慧1,2*
作者信息 +

Analysis of Impurities in Rifalazil

  • ZHANG Jing-xia1,2, XU Ming-qin1,2, CHEN Lin1,2, WANG Yu-chi1,2, ZHANG Chun-ran1,2, LI Zhe-yu1,2, SHI Ke-jin1,2, TANG Ke-hui1,2*
Author information +
文章历史 +

摘要

目的 对利福拉齐的杂质进行分析研究。 方法 HPLC对利福拉齐样品进行有关物质检查;TLC检测药品中残留侧链异丁基哌嗪;采用制备TLC、柱色谱法等分离手段对杂质进行分离纯化;HPLC结合TLC及UV、MS、NMR等分析手段对各杂质进行结构推测。结果 侧链异丁基哌嗪残留含量低于0.05%;杂质IM-1推测为2-氨基-3-叔丁基二甲基硅氧苯酚;杂质IM-2推测为25-去乙酰基-27-去甲氧基-利福拉齐;杂质IM-3推测为25-去乙酰基利福拉齐;杂质IM-4推测为利福拉齐的29位碳和15位碳断裂的副产物。结论 利福拉齐杂质的分析研究对利福拉齐的生产工艺改进具有重要意义。

Abstract

OBJECTIVE To analyze the impurities of rifalazil.METHODS HPLC method was used for related substances, TLC was used to detect the side chain isobutyl piperazine residues, TLC was prepared and column chromatography was used to separate impurities; HPLC was combined with TLC and UV,MS,NMR and other analytical tools was used to speculate the impurity.RESULTS Impurity IM-1 was to be 2-amino-3-(tert-butyldimethylsilyloxy)phenol, impurity IM-2 was to be 25-deacetyl-27-demethoxy rifalazil,impurity IM-3 was to be 25-deacetyl-rifalazil,IM-4 was to be rifalazil byproduct of 29 carbon and 15 carbon fracture.CONCLUSION The analysis of impurities in rifalazil products has important significance for the improvement of the production process of rifalazil.

关键词

利福拉齐 / 杂质 / 分析研究

Key words

rifalazil / impurity / analysis

引用本文

导出引用
张静霞,, 徐明琴,,陈林,,王宇驰,,张春然,,李喆宇,,石克金,,唐克慧,*. 利福拉齐杂质的分析研究[J]. 中国药学杂志, 2015, 50(7): 639-645 https://doi.org/10.11669/cpj.2015.07.016
ZHANG Jing-xia,, XU Ming-qin,, CHEN Lin,, WANG Yu-chi,, ZHANG Chun-ran,, LI Zhe-yu,, SHI Ke-jin,, TANG Ke-hui,*. Analysis of Impurities in Rifalazil[J]. Chinese Pharmaceutical Journal, 2015, 50(7): 639-645 https://doi.org/10.11669/cpj.2015.07.016
中图分类号: R917   

参考文献

[1] GUO Z Y,ZHEN Y,ZHAO W J. A new antituberculosis drug rifalazil.World Notes Antibiot (国外医药抗生素分册),2007,28(2):84-88.[2] CUI Y B, CAO S H, JIANG X L. Progress in studies of antituberculous agents.Chin J Antibiot(中国抗生素杂志),2010,35(5):321-333.[3] WANG T, ZHANG J X, CHENG H Q, et al. Determination of related substances in rifalazil by HPLC. Chin J Antibiot(中国抗生素杂志),2012,37(4):284-286.[4] MAE T,KONISHI E,HOSOE K,et al. Isolation and identication of major metabolites of rifalazil in mouse and human.Xenobiotica,1999, 29(11):1073-1087.
PDF(2162 KB)

Accesses

Citation

Detail

段落导航
相关文章

/